NASA’s Solar Dynamics Observatory 5 years & The Four Seasons (Vivaldi) – Video


NASA #39;s Solar Dynamics Observatory 5 years The Four Seasons (Vivaldi)
NASA #39;s Solar Dynamics Observatory 5 years The Four Seasons (Vivaldi) music: John Harrison with the Wichita State University Chamber Players: The Four Seasons (Vivaldi) ...

By: CLASSICAL MUSIC TV

Continue reading here:

NASA's Solar Dynamics Observatory 5 years & The Four Seasons (Vivaldi) - Video

Volokh Conspiracy: The truth about NASAs moon exploration

I see that NASA has proposed sending a submarine to Saturns moon Titan to explore its seas. Maybe this is a good idea in theory, but I dont know if I trust NASA on this one:

(1) Its not widely appreciated that these are the same guys who made our own Moon into a lifeless rock by removing all the lifeforms that existed on it.

(2) Also, priorities! NASA scientists are already aware of a planet entirely populated by robots why arent we exploring that one? Public cant handle that knowledge?

The robotic planet angle has already been covered elsewhere, so let me just focus on the Moon issue for now. I dont see how this doesnt get more play unlike the standard conspiracies, this is supported by verifiable fact!

Fact: About 46 years ago, NASA detected two lifeforms on the Moon. These lifeforms were able to use sophisticated technology, as NASA could easily verify from their audio and video transmissions that we intercepted. Ive actually seen the video, and the beings seemed humanoid to me, but quite frankly, I think its hard to say for sure because of the bulky protective shielding they were wearing at all times.

Fact: What did NASA do? Stuck these lifeforms onto a rocket and brought them to Earth! NASA did the same thing five more times over the next 3.5 years and brought back ten similar lifeforms. Every time NASA has detected lifeforms on the Moon every single time theyve removed them from the Moon and shipped them to Earth. Those might have been the twelve only lifeforms to have existed on the Moon intelligent, technologically sophisticated lifeforms and now the Moon is barren! (As far as we know. Could there be more such lifeforms evading detection? Im just asking.)

Fact: NASA conducted tests on them and then released them to live among us! Theyve been living among us for decades! The first lifeform ever detected on the Moon died a couple of years ago, and a couple more have also died over this time.

Now these guys want to mess up Titan? Wheres the outrage???

Sasha Volokh lives in Atlanta with his wife and three kids, and is an associate professor at Emory Law School. He has written numerous articles and commentaries on law and economics, privatization, antitrust, prisons, constitutional law, regulation, torts, and legal history.

Visit link:

Volokh Conspiracy: The truth about NASAs moon exploration

NASA to send submarine to Saturns moon Titan

Washington, Feb 17:

NASA is planning to send a nuclear-powered submarine to explore one of the methane seas located on Saturns moon Titan.

The single-tonne concept robot submarine is equipped with a seafloor camera and sampling system.

The submarine could fit into a space plane such as Boeings X-37, which was recently used for a classified Air Force mission.

The plane could land on Kraken Mare, the largest known body of liquid on Titan that consists mostly of liquid methane, or possibly drop the submarine using a parachute, ibtimes.com reported.

The vehicle would use conventional propulsors to yaw around, using a sun sensor to determine the initial azimuth to Earth and begin communication using a terrestrial radio as a more precise reference, NASA said.

NASA hopes to use the submarine to explore the chemistry of Titans seafloor and sea composition, as well as study its tides, weather, shoreline, islands and search for any type of life.

The submarine concept was showcased by NASA Glenns COMPASS Team and researchers from Applied Research Lab at the NASA Innovative Advanced Concepts (NIAC) Symposium in Florida.

The concept of the submarine is still in its very early stages, but the team expects that it may be up and running by 2047.

Measurement of the trace organic components of the sea, which perhaps may exhibit pre-biotic chemical evolution, will be an important objective, and a benthic sampler (a robotic grabber to sample sediment) would acquire and analyse sediment from the seabed, the US space agency explained.

Read this article:

NASA to send submarine to Saturns moon Titan

NASA/Industry EFT-1 Team Earns 2015 Douglas S. Morrow Public Outreach Award

On Dec. 5, 2014, the global space community watched as the Orion Multi-Purpose Crew Vehicle (MPCV) was launched aboard a Delta IV Heavy rocket from Kennedy Space Center. After a two-orbit, four-hour flight that took it further from Earth than any other human-rated spacecraft since Apollo 17 in 1972, it returned safely to a splashdown in the Pacific Ocean near California.

In his congratulations to NASA, Lockheed Martin, United Launch Alliance and the entire industry-government team involved with this successful first experimental test flight, Space Foundation Chief Executive Officer Elliot Pulham said, "The world is once again on a firm course of space exploration that will get us out of low Earth orbit, taking humans back to the Moon and on to Mars and beyond. As an early pathfinder for the Orion program, EFT-1 represents a gutsy effort by the entire Orion team to test early, test often and get ahead of the substantial risk involved with any new human rated system."

The flight was the first new U.S.-built human rated space launch system since 1981, and was launched to test various Orion systems, including separation events, avionics, heat shielding, parachutes and recovery operations.

The Space Foundation will honor the NASA/Industry EFT-1 Team for its historic accomplishment with the 2015 Douglas S. Morrow Public Outreach Award, to be presented on April 13 during the opening ceremony of the Space Foundation's 31st Space Symposium, co-sponsored by Northrop Grumman, and held at The Broadmoor in Colorado Springs, Colo., USA.

About the Morrow AwardThe award's namesake was an Academy Award-winning writer and producer, space advocate and early member of the board of directors of the Space Foundation. Designed to recognize those who have made significant contributions to public understanding of, and support for, space programs, the Morrow Award has a long list of distinguished recipients, including during the past decade:

2014 Col. Chris Hadfield (Ret.), former Canadian astronaut

2013 Bill Nye, CEO, The Planetary Society

2012 NASA Social Media Team

2011 Jay Barbree, NBC News; Marcia Dunn, The Associated Press; William Harwood, CBS News

2010 Leonard Nimoy, actor and director

More:

NASA/Industry EFT-1 Team Earns 2015 Douglas S. Morrow Public Outreach Award

Tau-Associated MAPT Gene Increases Risk for Alzheimer's Disease

Contact Information

Available for logged-in reporters only

Newswise An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, has identified the microtubule-associated protein tau (MAPT) gene as increasing the risk for developing Alzheimers disease (AD). The MAPT gene encodes the tau protein, which is involved with a number of neurodegenerative disorders, including Parkinsons disease (PD) and AD. These findings provide novel insight into Alzheimers neurodegeneration, possibly opening the door for improved clinical diagnosis and treatment.

The findings are published in the February 18 online issue of Molecular Psychiatry.

Alzheimers disease, which afflicts an estimated 5 million Americans, is typically characterized by progressive decline in cognitive skills, such as memory and language and behavioral changes. While some recent AD genome-wide association studies (GWAS), which search the entire human genome for small variations, have suggested that MAPT is associated with increased risk for AD, other studies have found no association. In comparison, a number of studies have found a strong association between MAPT and other neurodegenerative disorders, such as PD.

Though a tremendous amount of work has been conducted showing the involvement of the tau protein in Alzheimers disease, the role of the tau-associated MAPT gene is still unclear, said Rahul S. Desikan, MD, PhD, research fellow and radiology resident at the UC San Diego School of Medicine and the studys first author.

In the new Molecular Psychiatry paper, conducted with collaborators across the country and world, Desikan and colleagues narrowed their search. Rather than looking at all possible loci (specific gene locations), the authors only focused on loci associated with PD and assessed whether these loci were also associated with AD, thus increasing their statistical power for AD gene discovery.

By using this approach, they found that carriers of the deleterious MAPT allele (an alternative form of the gene) are at increased risk for developing AD and more likely to experience increased brain atrophy than non-carriers.

"This study demonstrates that tau deposits in the brains of Alzheimer's disease subjects are not just a consequence of the disease, but actually contribute to development and progression of the disease," said Gerard Schellenberg, PhD, professor of pathology and laboratory medicine at the University of Pennsylvania, principal investigator of the Alzheimers Disease Genetics Consortium and a study co-author.

An important aspect was the collaborative nature of this work. Thanks to our collaborators from the Consortium, the International Parkinsons Disease Genetics Consortium, the Genetic and Environmental Risk in Alzheimers Disease, the Cohorts for Heart and Aging Research in Genomic Epidemiology, deCODE Genetics and the DemGene cohort, we had tremendous access to a large number of Alzheimers and Parkinsons genetic datasets that we could use to identify and replicate our MAPT finding, said Ole A. Andreassen, MD, PhD, professor of biological psychiatry at the University of Oslo and a senior co-author.

More:

Tau-Associated MAPT Gene Increases Risk for Alzheimer's Disease

Taco’s & Trooper – Slender Fortress – #3 Dieing to get medicine – Video


Taco #39;s Trooper - Slender Fortress - #3 Dieing to get medicine
In this part, we continue our journey in the mansion to cure our amnesia problem, but run into some trouble along the way. Lesson? Wait. For. Grace.* * Grace: After a set amount of time,...

By: ShiningMario

Read this article:

Taco's & Trooper - Slender Fortress - #3 Dieing to get medicine - Video

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 – Video


Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015
Market Research Reports, Inc. has announced the addition of Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Strategic Analysis of Industry Trends, ...

By: Market Research Reports, Inc.

Read more:

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market 2015 - Video

General Medicine, The Post-Hospitalist Company Achieves Readmission Rates Better than 95% of CMS National Peer Group

(PRWEB) February 17, 2015

Partner facilities of General Medicine, The Post-Hospitalist Company, attained an average hospital readmission rate of 4.8% for all of 2013, according to the Centers for Medicare and Medicaid Services (CMS). The 2013 Quality and Resource Use Reportcompiled by CMS and finalized September 2014found that General Medicine, The Post-Hospitalist Company, achieved readmission rates 70% lower than all providers within its national peer group. With the peer groups average rate coming in at 16.4%, this puts General Medicine in the top five percent of post-hospitalist/SNFist providers nationwide.

CMSs report corroborates similar findings made by the University of Illinois Chicago (UIC) in a February 2013 review of the performance of the State of Illinois Integrated Care Plan in its first year. As the designated post-hospitalist/SNFist Program Provider for this plan, General Medicine has streamlined much of the states care for elderly patients.

UICs independent study identified an 18% reduction in the rate of hospital admissions/readmissions coupled with a 25% decrease in hospital lengths of stay. Additionally, UIC reported a 39% decrease in the percentage of high frequency emergency department usage and a 15% decrease in the rate of ER visits resulting in an inpatient hospital admission. Physicians and nurse practitioners provided through General Medicine were responsible for the overall care of all of the plans enrollees/members during this initial operational year.

CMSs report also established General Medicines quality metrics to be 48.4% better than its peer group, when comparing data relevant to the organizations medical services. The following quality metrics were considered in these measurements: falls plan of care, advance care plan, high blood pressure screening and follow up, influenza immunization, diabetic foot exam, colorectal cancer screening, and CAD antiplatelet therapy. This rating by CMS places General Medicine, The Post-Hospitalist Company in the top 5% for quality metrics among its peer group.

This data is indicative of General Medicine, The Post-Hospitalist Companys continued efforts to improve post-hospital care while decreasing overall spending.

About General Medicine, The Post-Hospitalist Company:

General Medicine, The Post-Hospitalist Company, specializes in the care of patients living in post-acute and long-term care settings. Post-hospitalists hold regular, on-site office hours and pride themselves on quickly responding to calls and improving quality of care. With low staff turnover and 24/7 service, General Medicine, The Post-Hospitalist Company, helps facilities decrease hospital readmission rates and unnecessary ER visits.

Specific Benefits of General Medicine, the Post-Hospitalist Companys Services Include:

Key Successes of General Medicine, The Post-Hospitalist Company:

The rest is here:

General Medicine, The Post-Hospitalist Company Achieves Readmission Rates Better than 95% of CMS National Peer Group